ethinyl estradiol
ethinyl estradiol: 6 clinical trials tracked.
ethinyl estradiol evidence translation
What we can confirm
6 tracked trials
What it means
What to watch
Prepared research question
What is verified about ethinyl estradiol, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 4 study sponsors
Clinical Trial Registry Records (6)
A Phase 1b, Open Label, 2-Part Study to Evaluate the Effect of Pelabresib (DAK539/CPI-0610) on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Patients With Advanced Malignancies
Primary endpoint: Maximum Plasma Concentration (Cmax) of repaglinide, midazolam, and drospirenone and ethinyl estradiol
A Phase 1 Study to Assess the Effect of Multiple Doses of ABBV-722 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Ethinyl Estradiol and Levonorgestrel
A Phase 1 Drug-Drug Interaction Study of ABBV-295, Levonorgestrel, and Ethinyl Estradiol in Healthy Adult Female Subjects With Overweight or Obesity
Primary endpoint: Number of Participants with Adverse Events (AEs)
A Phase 1, Open-Label Study to Evaluate the Effect of Elenestinib on the Pharmacokinetics of Midazolam and Combined Oral Contraceptives, Levonorgestrel/Ethinyl Estradiol, in Healthy Adult Female Participants
Primary endpoint: Area under the concentration-time curve, from time 0 to the last observed non-zero concentration (AUC0-t)
A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Oral Doses of Bemnifosbuvir/Ruzasvir Fixed-dose Combination on the Single-Dose Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/ Levonorgestrel) in Healthy Adult Female Participants of Non-Childbearing Potential
Primary endpoint: PK of EE/LNG (Cmax)
An Open-label, Single-sequence Multiple Cohort Study to Assess the Effect of Multiple Doses of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on the Pharmacokinetics of Single Doses of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
Primary endpoint: Area under the concentration-time curve from time 0 to infinity (AUCinf) of EE and LEVO